Hashemi Goradel et al. [94] summarised the possible mechanisms of Fn action in CRC in a 2018 publication, listing these as immunomodulation, virulence factors, miRNAs, and bacterial metabolism. The gene discussed is FN1; the disease is colorectal carcinoma.